JP2002507222A - ペルヒドロイソインドール置換体の製造方法 - Google Patents
ペルヒドロイソインドール置換体の製造方法Info
- Publication number
- JP2002507222A JP2002507222A JP50653499A JP50653499A JP2002507222A JP 2002507222 A JP2002507222 A JP 2002507222A JP 50653499 A JP50653499 A JP 50653499A JP 50653499 A JP50653499 A JP 50653499A JP 2002507222 A JP2002507222 A JP 2002507222A
- Authority
- JP
- Japan
- Prior art keywords
- formula
- compound
- amine
- salt
- solvent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- ODSNARDHJFFSRH-UHFFFAOYSA-N 2,3,3a,4,5,6,7,7a-octahydro-1h-isoindole Chemical class C1CCCC2CNCC21 ODSNARDHJFFSRH-UHFFFAOYSA-N 0.000 title claims description 6
- 238000004519 manufacturing process Methods 0.000 title description 2
- 150000001875 compounds Chemical class 0.000 claims abstract description 27
- 150000003839 salts Chemical class 0.000 claims abstract description 17
- 238000000034 method Methods 0.000 claims abstract description 13
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 45
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 15
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 claims description 12
- 150000001412 amines Chemical class 0.000 claims description 10
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 claims description 9
- 239000002904 solvent Substances 0.000 claims description 9
- 239000010948 rhodium Substances 0.000 claims description 8
- SJRJJKPEHAURKC-UHFFFAOYSA-N N-Methylmorpholine Chemical compound CN1CCOCC1 SJRJJKPEHAURKC-UHFFFAOYSA-N 0.000 claims description 6
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 claims description 6
- RQEUFEKYXDPUSK-SSDOTTSWSA-N (1R)-1-phenylethanamine Chemical compound C[C@@H](N)C1=CC=CC=C1 RQEUFEKYXDPUSK-SSDOTTSWSA-N 0.000 claims description 5
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 5
- 239000011575 calcium Substances 0.000 claims description 5
- 229910052791 calcium Inorganic materials 0.000 claims description 5
- 239000002253 acid Substances 0.000 claims description 4
- 239000003054 catalyst Substances 0.000 claims description 4
- PAFZNILMFXTMIY-UHFFFAOYSA-N cyclohexylamine Chemical compound NC1CCCCC1 PAFZNILMFXTMIY-UHFFFAOYSA-N 0.000 claims description 4
- 239000000010 aprotic solvent Substances 0.000 claims description 3
- 159000000007 calcium salts Chemical class 0.000 claims description 3
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 claims description 3
- 229910052703 rhodium Inorganic materials 0.000 claims description 3
- MHOVAHRLVXNVSD-UHFFFAOYSA-N rhodium atom Chemical compound [Rh] MHOVAHRLVXNVSD-UHFFFAOYSA-N 0.000 claims description 3
- 238000009876 asymmetric hydrogenation reaction Methods 0.000 claims description 2
- 238000010438 heat treatment Methods 0.000 claims description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 2
- 239000011707 mineral Substances 0.000 claims description 2
- KLZYRCVPDWTZLH-UHFFFAOYSA-N 2,3-dimethylsuccinic acid Chemical compound OC(=O)C(C)C(C)C(O)=O KLZYRCVPDWTZLH-UHFFFAOYSA-N 0.000 claims 1
- 230000002378 acidificating effect Effects 0.000 claims 1
- 230000015572 biosynthetic process Effects 0.000 abstract description 3
- 238000003786 synthesis reaction Methods 0.000 abstract description 2
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 27
- 239000000243 solution Substances 0.000 description 11
- 239000000047 product Substances 0.000 description 9
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 description 8
- 238000002844 melting Methods 0.000 description 7
- 230000008018 melting Effects 0.000 description 7
- 239000000203 mixture Substances 0.000 description 7
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 6
- 238000005984 hydrogenation reaction Methods 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 229960005069 calcium Drugs 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- BFMKBYZEJOQYIM-UCGGBYDDSA-N tert-butyl (2s,4s)-4-diphenylphosphanyl-2-(diphenylphosphanylmethyl)pyrrolidine-1-carboxylate Chemical compound C([C@@H]1C[C@@H](CN1C(=O)OC(C)(C)C)P(C=1C=CC=CC=1)C=1C=CC=CC=1)P(C=1C=CC=CC=1)C1=CC=CC=C1 BFMKBYZEJOQYIM-UCGGBYDDSA-N 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 150000008064 anhydrides Chemical class 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- -1 benzylidene succinic acid dimethyl succinic acid Chemical compound 0.000 description 2
- LLSDKQJKOVVTOJ-UHFFFAOYSA-L calcium chloride dihydrate Chemical compound O.O.[Cl-].[Cl-].[Ca+2] LLSDKQJKOVVTOJ-UHFFFAOYSA-L 0.000 description 2
- 229940052299 calcium chloride dihydrate Drugs 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- DULADNUZAALJPZ-BBQUMCNBSA-N (2s)-4-[(3ar,7as)-1,3,3a,4,5,6,7,7a-octahydroisoindol-2-yl]-2-benzyl-4-oxobutanoic acid;(1r)-1-phenylethanamine Chemical compound C[C@@H]([NH3+])C1=CC=CC=C1.C([C@@H](CC(=O)N1C[C@@H]2CCCC[C@@H]2C1)C(=O)[O-])C1=CC=CC=C1 DULADNUZAALJPZ-BBQUMCNBSA-N 0.000 description 1
- WHRPHGQMEZWMNF-UHFFFAOYSA-N 3-benzylideneoxolane-2,5-dione Chemical compound O=C1OC(=O)CC1=CC1=CC=CC=C1 WHRPHGQMEZWMNF-UHFFFAOYSA-N 0.000 description 1
- ZXVXJGMFEGAQEI-IYBDPMFKSA-N 4-[(3as,7ar)-1,3,3a,4,5,6,7,7a-octahydroisoindol-2-yl]-2-benzylidene-4-oxobutanoic acid Chemical compound C([C@@H]1CCCC[C@@H]1C1)N1C(=O)CC(C(=O)O)=CC1=CC=CC=C1 ZXVXJGMFEGAQEI-IYBDPMFKSA-N 0.000 description 1
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonium chloride Substances [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- DXGOUNPUYXJXOB-VNMUXGFYSA-N C(C1=CC=CC=C1)[C@H](C(=O)O)CC(N1C[C@H]2CCCC[C@H]2C1)=O.N1CCOCC1 Chemical compound C(C1=CC=CC=C1)[C@H](C(=O)O)CC(N1C[C@H]2CCCC[C@H]2C1)=O.N1CCOCC1 DXGOUNPUYXJXOB-VNMUXGFYSA-N 0.000 description 1
- MUXOBHXGJLMRAB-UHFFFAOYSA-N Dimethyl succinate Chemical compound COC(=O)CCC(=O)OC MUXOBHXGJLMRAB-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 1
- 235000011114 ammonium hydroxide Nutrition 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000007810 chemical reaction solvent Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 150000002780 morpholines Chemical class 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 238000011403 purification operation Methods 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 238000007142 ring opening reaction Methods 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/44—Iso-indoles; Hydrogenated iso-indoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Endocrinology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Indole Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1.式(I): で表されるペルヒドロイソインドール置換体、及び薬学的に許容しうるその塩類 の工業的製造方法であって、メタノール性媒体中でジメチルコハク酸をベンズア ルデヒドと反応させて、式(II): の二塩基酸を得て、それを非プロトン性媒体中で無水酢酸の存在下で加熱して、 式(III): の無水物を得て、それを非プロトン性溶媒中で、式(IV): のペルヒドロイソインドールと反応させ、式(V): の化合物を得て、それをメタノール溶媒又は塩化メチレン溶媒中で、錯体ロジウ ム/(2S,4S)−N−ブトキシカルボニル−4−ジフェニルホスホイノ−2 −ジフェニルホスホイノ−メチルピロリジン、すなわちRh/(S,S)BPP Mを、不斉水素化触媒として用いて接触水素化し、アミンAの存在下で塩に転化 して、式(VI): を得る方法であり、ここで鉱塩存在下の塩基性溶媒中では、式(I)の化合物の 付加塩を得て、望むならば、対応する酸に転換するか、又は、酸性溶媒中では式 (I)の化合物を得て、望むならば薬学的に許容しうる付加塩に転換することを 特徴とする方法。 2.用いるアミンAが、(R)−1−フェニルエチルアミンである、請求項1記 載の方法。 3.アミンAが、モルホリンである、請求項1記載の方法。 4.アミンAが、N−メチルモルホリンである、請求項1記載の方法。 5.アミンAが、シクロヘキシルアミンである、請求項1記載の方法。 6.ビス−2−(S)−ベンジル−4−オキソ−4−(シス−ペルヒドロイソイ ンドール−2−イル)ブチル酸のカルシウム塩を製造するための、請求項1記載 の方法。 7.カルシウム ビス−2−(S)−ベンジル−4−オキソ−4−(シス−ペル ヒドロイソインドール−2−イル)ブチレート2水和物を製造するための、請求 項1記載の方法。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9708431A FR2765578B1 (fr) | 1997-07-03 | 1997-07-03 | Procede de preparation d'un perhydroisoindole substitue |
FR97/08431 | 1997-07-03 | ||
PCT/FR1998/001405 WO1999001430A1 (fr) | 1997-07-03 | 1998-07-01 | Procede de preparation d'un perhydroisoindole substitue |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2002507222A true JP2002507222A (ja) | 2002-03-05 |
JP4056093B2 JP4056093B2 (ja) | 2008-03-05 |
Family
ID=9508815
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP50653499A Expired - Fee Related JP4056093B2 (ja) | 1997-07-03 | 1998-07-01 | ペルヒドロイソインドール置換体の製造方法 |
Country Status (22)
Country | Link |
---|---|
US (1) | US6133454A (ja) |
EP (1) | EP0994854B1 (ja) |
JP (1) | JP4056093B2 (ja) |
KR (1) | KR100421073B1 (ja) |
CN (1) | CN1108291C (ja) |
AT (1) | ATE224368T1 (ja) |
AU (1) | AU734398B2 (ja) |
BR (1) | BR9810657A (ja) |
CA (1) | CA2295992C (ja) |
DE (1) | DE69808092T2 (ja) |
DK (1) | DK0994854T3 (ja) |
EA (1) | EA002151B1 (ja) |
ES (1) | ES2184304T3 (ja) |
FR (1) | FR2765578B1 (ja) |
HK (1) | HK1028610A1 (ja) |
HU (1) | HUP0002778A3 (ja) |
NO (1) | NO313095B1 (ja) |
NZ (1) | NZ501835A (ja) |
PL (1) | PL190861B1 (ja) |
PT (1) | PT994854E (ja) |
WO (1) | WO1999001430A1 (ja) |
ZA (1) | ZA985882B (ja) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007176824A (ja) * | 2005-12-27 | 2007-07-12 | Kissei Pharmaceut Co Ltd | 不斉還元方法 |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2793411B1 (fr) * | 1999-05-11 | 2001-06-29 | Synthelabo | Utilisation de derives de l'acide succinique pour obtenir un medicament destine au traitement de l'inflammation |
FR2834892B1 (fr) * | 2002-01-23 | 2004-02-27 | Servier Lab | Composition pharmaceutique orodispersible de mitiglinide |
US6684422B2 (en) * | 2002-02-27 | 2004-02-03 | Ginger Magnolia | Toy retention blanket and system |
EP1532979A4 (en) * | 2002-06-28 | 2008-01-16 | Kissei Pharmaceutical | DRUG COMPOSITION FOR REGULATING GLYCEMIA |
KR100709531B1 (ko) * | 2002-06-28 | 2007-04-23 | 깃세이 야쿠힌 고교 가부시키가이샤 | 당뇨병성 합병증의 예방 또는 진전저지용 의약조성물 |
KR20050058444A (ko) * | 2002-08-23 | 2005-06-16 | 반유 세이야꾸 가부시끼가이샤 | 인돌로피롤로카르바졸 유도체의 제조법 |
FR2860231B1 (fr) * | 2003-09-25 | 2005-11-18 | Servier Lab | Nouveau procede de preparation du cis-octahydro-isoindole |
US7230022B2 (en) * | 2004-02-19 | 2007-06-12 | Bristol-Myers Squibb Company | Substituted fused bicyclic amines as modulators of chemokine receptor activity |
CN1634885B (zh) * | 2004-11-09 | 2011-05-04 | 北京乐力健生物科技有限公司 | 米格列奈晶型及其制备方法 |
CN1324010C (zh) * | 2005-01-12 | 2007-07-04 | 江苏省药物研究所 | 一种米格列奈的制备方法 |
WO2009047797A2 (en) * | 2007-10-08 | 2009-04-16 | Ind-Swift Laboratories Limited | Process for the preparation of perhydroisoindole derivative |
CN102382033B (zh) * | 2010-08-31 | 2013-04-03 | 凯瑞斯德生化(苏州)有限公司 | 一种光学活性米格列奈酯及米格列奈盐的制备方法 |
EP3492108A1 (en) | 2011-06-10 | 2019-06-05 | Bluebird Bio, Inc. | Gene therapy vectors for adrenoleukodystrophy and adrenomyeloneuropathy |
KR101327866B1 (ko) * | 2011-10-27 | 2013-11-11 | 주식회사 메디켐코리아 | 미티글리나이드 칼슘염의 개선된 제조방법 |
ES2546362B1 (es) | 2012-06-22 | 2016-07-07 | Laboratorios Lesvi, S. L. | PROCEDIMIENTO DE OBTENCIÓN DEL ÁCIDO (S) -2 BENCIL 4 - ((3aR, 7aS) -HEXAHIDRO-1H-ISOINDOL-2 (3H) IL) -4-OXOBUTANOICO Y SUS SALES |
CN103450069B (zh) * | 2013-06-24 | 2015-04-15 | 山西大同大学 | 一种米格列奈钙的制备方法 |
CN103709092B (zh) * | 2013-11-04 | 2016-07-06 | 河北科技大学 | 米格列奈钙的制备方法 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU654331B2 (en) * | 1991-03-30 | 1994-11-03 | Kissei Pharmaceutical Co. Ltd. | Succinic acid compounds |
-
1997
- 1997-07-03 FR FR9708431A patent/FR2765578B1/fr not_active Expired - Fee Related
-
1998
- 1998-07-01 AT AT98935072T patent/ATE224368T1/de not_active IP Right Cessation
- 1998-07-01 US US09/446,848 patent/US6133454A/en not_active Expired - Fee Related
- 1998-07-01 PT PT98935072T patent/PT994854E/pt unknown
- 1998-07-01 EA EA200000094A patent/EA002151B1/ru not_active IP Right Cessation
- 1998-07-01 EP EP98935072A patent/EP0994854B1/fr not_active Expired - Lifetime
- 1998-07-01 CN CN98806779A patent/CN1108291C/zh not_active Expired - Fee Related
- 1998-07-01 NZ NZ501835A patent/NZ501835A/xx unknown
- 1998-07-01 CA CA002295992A patent/CA2295992C/fr not_active Expired - Fee Related
- 1998-07-01 DK DK98935072T patent/DK0994854T3/da active
- 1998-07-01 JP JP50653499A patent/JP4056093B2/ja not_active Expired - Fee Related
- 1998-07-01 AU AU84450/98A patent/AU734398B2/en not_active Ceased
- 1998-07-01 HU HU0002778A patent/HUP0002778A3/hu unknown
- 1998-07-01 ES ES98935072T patent/ES2184304T3/es not_active Expired - Lifetime
- 1998-07-01 WO PCT/FR1998/001405 patent/WO1999001430A1/fr active IP Right Grant
- 1998-07-01 BR BR9810657-0A patent/BR9810657A/pt not_active Application Discontinuation
- 1998-07-01 DE DE69808092T patent/DE69808092T2/de not_active Expired - Lifetime
- 1998-07-01 PL PL337728A patent/PL190861B1/pl not_active IP Right Cessation
- 1998-07-02 KR KR10-1998-0026520A patent/KR100421073B1/ko not_active IP Right Cessation
- 1998-07-03 ZA ZA985882A patent/ZA985882B/xx unknown
-
1999
- 1999-12-30 NO NO19996577A patent/NO313095B1/no not_active IP Right Cessation
-
2000
- 2000-12-15 HK HK00108117A patent/HK1028610A1/xx not_active IP Right Cessation
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007176824A (ja) * | 2005-12-27 | 2007-07-12 | Kissei Pharmaceut Co Ltd | 不斉還元方法 |
WO2007077818A1 (ja) * | 2005-12-27 | 2007-07-12 | Kissei Pharmaceutical Co., Ltd. | 不斉還元方法 |
US7847107B2 (en) | 2005-12-27 | 2010-12-07 | Kissei Pharmaceutical Co., Ltd. | Asymmetric reduction method |
KR101437078B1 (ko) | 2005-12-27 | 2014-09-02 | 깃세이 야쿠힌 고교 가부시키가이샤 | 비대칭 환원방법 |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2002507222A (ja) | ペルヒドロイソインドール置換体の製造方法 | |
IL95480A (en) | Process for the preparation of cyclic amino acids and intermediates | |
JP2002506844A (ja) | シクロヘキシリデンアミンのcis−選択的接触水素化方法 | |
WO2005044805A1 (fr) | Procede d'elaboration de donepezil et de ses derives | |
US5371237A (en) | Process for the production of 4-hydroxy-2-oxopyrrolidin-1-yl-acetamide | |
WO2010078250A1 (en) | Synthesis of (2-amino)-tetrahydrocarbazole-propanoic acid | |
JPS6120547B2 (ja) | ||
US5099067A (en) | Use of ammonium formate as a hydrogen transfer reagent for reduction of chiral nitro compounds with retention of configuration | |
JP3046463B2 (ja) | 2−アミノ−5,6−ジメトキシ−テトラリンの製造方法 | |
JP4597141B2 (ja) | エンアミド誘導体の新規合成方法 | |
EP0598383B1 (en) | Process for the preparation of 5,6-diacetoxyindole | |
MXPA99011657A (en) | Method for preparing a substituted perhydroisoindole | |
US5395963A (en) | Process for chloronitroacetic acid esters | |
JP2004504261A (ja) | 水素化第一アミンの製造 | |
JP3704738B2 (ja) | 1−クロロ置換フェニルアルキルアミン類の製造方法 | |
JPH11310558A (ja) | 2―アミノ―4,5,3’,4’―テトラメトキシベンゾフェノンの製造方法 | |
HUT73809A (en) | 4-amino-3-hydroxy-phthalimidine and process for producing it | |
Sun et al. | An efficient synthesis of 2-(((9-fluorenylmethoxycarbonyl) amino) methyl) benzoic acid | |
JPH0331282A (ja) | 新規オクタヒドロ―インドーロ〔2,3―a〕キノリジンジエステル誘導体及びその塩並びにそれらの調製方法 | |
JPS589096B2 (ja) | 1− アシル −2− メチルインドリル −3− アルカンサンノセイホウ | |
JPS6136507B2 (ja) | ||
PL210125B1 (pl) | Sposób otrzymywania kwasów O-acylowinowych | |
JP2001328993A (ja) | 光学活性ホスフィン化合物 | |
JPS5821625B2 (ja) | アミノチカンフエニルケトンユウドウタイノ セイホウ | |
GB2106505A (en) | Tryptamine derivatives and processes for their preparation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20060516 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20060816 |
|
A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A711 Effective date: 20061107 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20071204 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20071211 |
|
R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20101221 Year of fee payment: 3 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20111221 Year of fee payment: 4 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20111221 Year of fee payment: 4 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20121221 Year of fee payment: 5 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20131221 Year of fee payment: 6 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
LAPS | Cancellation because of no payment of annual fees |